Functions of neutral ceramidase in the Golgi apparatus

Ceramidases hydrolyze ceramides into sphingosine and fatty acids, with sphingosine being further metabolized into sphingosine-1-phosphate (S1P); thus, ceramidases control the levels of these bioactive sphingolipids in cells and tissues. Neutral ceramidase (nCDase) is highly expressed in colorectal tissues, and a recent report showed that nCDase activity is involved in Wnt/β-catenin signaling. In addition, the inhibition of nCDase decreases the development and progression of colorectal tumor growth. Here, to determine the action of nCDase in colorectal cancer cells, we focused on the subcellular localization and metabolic functions of this enzyme in HCT116 cells. nCDase was found to be located in both the plasma membrane and in the Golgi apparatus, but it had minimal effects on basal levels of ceramide, sphingosine, or S1P. Cells overexpressing nCDase were protected from the cell death and Golgi fragmentation induced by C6-ceramide, and they showed reduced levels of C6-ceramide and higher levels of S1P and sphingosine. Furthermore, compartment-specific metabolic functions of the enzyme were probed using C6-ceramide and Golgi-targeted bacterial SMase (bSMase) and bacterial ceramidase (bCDase). The results showed that Golgi-specific bCDase also demonstrated resistance against the cell death stimulated by C6-ceramide, and it catalyzed the metabolism of ceramides and produced sphingosine in the Golgi. Targeting bSMase to the Golgi resulted in increased levels of ceramide that were attenuated by the expression of nCDase, also supporting its ability to metabolize Golgi-generated ceramide. These results are critical in understanding the functions of nCDase actions in colorectal cancer cells as well as the compartmentalized pathways of sphingolipid metabolism.

[1]  Y. Hannun,et al.  Ceramidases, roles in sphingolipid metabolism and in health and disease. , 2017, Advances in biological regulation.

[2]  Y. Hannun,et al.  Role of neutral ceramidase in colon cancer , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Y. Hannun,et al.  Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death. , 2016, The Biochemical journal.

[4]  Y. Hannun,et al.  Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death* , 2015, Journal of Biological Chemistry.

[5]  W. J. Allen,et al.  Structural Basis for Ceramide Recognition and Hydrolysis by Human Neutral Ceramidase. , 2015, Structure.

[6]  M. Kester,et al.  Preclinical development of a C6-ceramide NanoLiposome, a novel sphingolipid therapeutic , 2015, Biological chemistry.

[7]  Y. Hannun,et al.  Sphingosine 1-phosphate induces filopodia formation through S1PR2 activation of ERM proteins. , 2013, The Biochemical journal.

[8]  Y. Hannun,et al.  Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease. , 2012, Prostaglandins & other lipid mediators.

[9]  M. Cabot,et al.  C6-Ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth , 2012, Breast Cancer Research and Treatment.

[10]  Y. Hannun,et al.  Many Ceramides* , 2011, The Journal of Biological Chemistry.

[11]  Y. Hannun,et al.  Novel Pathway of Ceramide Production in Mitochondria , 2011, The Journal of Biological Chemistry.

[12]  J. Norris,et al.  Autophagy is increased in prostate cancer cells over-expressing acid ceramidase and enhances resistance to C6-ceramide , 2010, Prostate Cancer and Prostatic Diseases.

[13]  M. Kester,et al.  Transcriptional Regulation of the Human Neutral Ceramidase Gene , 2009, Archives of biochemistry and biophysics.

[14]  M. Nikolova-Karakashian,et al.  Ceramide in Stress Response , 2010, Advances in experimental medicine and biology.

[15]  B. Yang,et al.  Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition , 2010, Oncogene.

[16]  A. Gomez-Muñoz,et al.  Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease. , 2010, Progress in lipid research.

[17]  Wei Hu,et al.  Substrate Specificity, Membrane Topology, and Activity Regulation of Human Alkaline Ceramidase 2 (ACER2)* , 2010, The Journal of Biological Chemistry.

[18]  Y. Hannun,et al.  An overview of sphingolipid metabolism: from synthesis to breakdown. , 2010, Advances in experimental medicine and biology.

[19]  A. Bielawska,et al.  Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). , 2010, Advances in experimental medicine and biology.

[20]  V. Brinkmann.  FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system , 2009, British journal of pharmacology.

[21]  Y. Hannun,et al.  Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation. , 2009, Biochimica et biophysica acta.

[22]  Y. Hannun,et al.  Bioactive sphingolipids: metabolism and function This work was supported by National Institutes of Health Grants GM-43825 and CA-87584. Published, JLR Papers in Press, November 17, 2008. , 2009, Journal of Lipid Research.

[23]  Y. Hannun,et al.  The sphingolipid salvage pathway in ceramide metabolism and signaling. , 2008, Cellular signalling.

[24]  Yusuf A. Hannun,et al.  Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.

[25]  J. Pfeilschifter,et al.  Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy. , 2006, Current pharmaceutical design.

[26]  A. Bielawska,et al.  Neutral Ceramidase Encoded by the Asah2 Gene Is Essential for the Intestinal Degradation of Sphingolipids* , 2006, Journal of Biological Chemistry.

[27]  Y. Hannun,et al.  Identification of a novel amidase motif in neutral ceramidase. , 2006, The Biochemical journal.

[28]  K. Hanada,et al.  Discovery of the molecular machinery CERT for endoplasmic reticulum-to-Golgi trafficking of ceramide , 2006, Molecular and Cellular Biochemistry.

[29]  R. Schwabe,et al.  Roles for C16-ceramide and Sphingosine 1-Phosphate in Regulating Hepatocyte Apoptosis in Response to Tumor Necrosis Factor-α* , 2005, Journal of Biological Chemistry.

[30]  M. Tani,et al.  Subcellular localization of human neutral ceramidase expressed in HEK293 cells. , 2005, Biochemical and biophysical research communications.

[31]  Y. Hannun,et al.  Golgi fragmentation is associated with ceramide-induced cellular effects. , 2005, Molecular biology of the cell.

[32]  Satoshi Yasuda,et al.  Molecular machinery for non-vesicular trafficking of ceramide , 2003, Nature.

[33]  J. Pfeilschifter,et al.  Nitric oxide induces neutral ceramidase degradation by the ubiquitin/proteasome complex in renal mesangial cell cultures , 2002, FEBS letters.

[34]  Y. Hannun,et al.  Biochemical Mechanisms of the Generation of Endogenous Long Chain Ceramide in Response to Exogenous Short Chain Ceramide in the A549 Human Lung Adenocarcinoma Cell Line , 2002, The Journal of Biological Chemistry.

[35]  J. Pfeilschifter,et al.  Interleukin-1β Induces Chronic Activation and de Novo Synthesis of Neutral Ceramidase in Renal Mesangial Cells* , 2001, The Journal of Biological Chemistry.

[36]  A. Bielawska,et al.  Structural requirements of ceramide and sphingosine based inhibitors of mitochondrial ceramidase. , 2001, Biochemistry.

[37]  A. Bielawska,et al.  Cloning and Characterization of a Novel Human Alkaline Ceramidase , 2001, The Journal of Biological Chemistry.

[38]  A. Bielawska,et al.  Molecular Cloning and Characterization of a Human Mitochondrial Ceramidase* , 2000, The Journal of Biological Chemistry.

[39]  W. Stoffel,et al.  Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Haimovitz-Friedman,et al.  12-O-tetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. , 1998, Cancer Research.

[41]  Y. Hannun.  Functions of Ceramide in Coordinating Cellular Responses to Stress , 1996, Science.

[42]  R. Pagano,et al.  A vital stain for the Golgi apparatus. , 1985, Science.

[43]  H. Moser,et al.  Ceramidase Deficiency in Farber's Disease (Lipogranulomatosis) , 1972, Science.